StemPoint Capital: Biotech-Focused Hedge Fund Insight
In the bustling financial heart of New York, a small hedge fund is quietly reshaping how investors approach the life sciences sector. StemPoint Capital LP, founded in 2023, has established itself as a distinctive player by blending rigorous scientific research with disciplined investment strategies. The firm’s focus on biopharmaceuticals, biotechnology, and healthcare equities positions it…
